Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27647583 | 0.91 | ALDH1A1 (0.38) | FDPSALDH1A1TDP1DNM1OPRM1 | |
| SCHEMBL27761566 | 0.89 | FDPS (0.46) | FDPSDNM1OPRM1SMPD1 | |
| SCHEMBL28589370 | 0.88 | FDPS (0.34) | FDPSCA2CA1 | |
| SCHEMBL29159276 | 0.86 | FDPS (0.34) | FDPSALDH1A1TDP1DNM1OPRM1 | |
| SCHEMBL302193 | 0.80 | FDPS (0.37) | FDPSALDH1A1TDP1DNM1OPRM1 | |
| SCHEMBL6021613 | 0.79 | DNM1 (0.44) | FDPSALDH1A1DNM1SMPD1TSHR | |
| Hydrochloric Acid SCHEMBL5088126 | 0.78 | FDPS (0.35) | FDPSALDH1A1TDP1DNM1OPRM1 | |
| SCHEMBL22027682 | 0.78 | TSHR (0.38) | FDPSALDH1A1TDP1DNM1OPRM1 | |
| SCHEMBL15797814 | 0.78 | ALDH1A1 (0.39) | FDPSALDH1A1TDP1DNM1OPRM1 | |
| Iodide SCHEMBL5091363 | 0.78 | FDPS (0.35) | FDPSALDH1A1TDP1DNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158476-A1 | MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2024-05-16 | — | — | US | claimed |
| CN-111601626-B | Medical device with integrated biosensor | 生物克瑞德公司 | 2022-05-06 | — | — | CN | claimed |
| US-20210380420-A1 | MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2021-12-09 | — | — | US | claimed |
| US-20210220523-A1 | NO RELEASING COATED PROSTHETIC VASCULAR GRAFTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2021-07-22 | — | — | US | claimed |
| EP-3826628-A1 | NO RELEASING COATED PROSTHETIC VASCULAR GRAFTS | University of Georgia Research Foundation, Inc. (US) | 2021-06-02 | — | — | EP | claimed |
| EP-3823683-A1 | ROBUST NITRIC OXIDE-RELEASING POLYMERS AND ARTICLES AND METHODS OF MAKING AND USES THEREOF | University of Georgia Research Foundation, Inc. (US) | 2021-05-26 | — | — | EP | claimed |
| CN-111601626-A | Medical device with integrated biosensor | 生物克瑞德公司 | 2020-08-28 | — | — | CN | claimed |
| WO-2020041617-A1 | NO RELEASING COATED PROSTHETIC VASCULAR GRAFTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2020-02-27 | — | — | WO | claimed |
| WO-2020018488-A1 | ROBUST NITRIC OXIDE-RELEASING POLYMERS AND ARTICLES AND METHODS OF MAKING AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2020-01-23 | — | — | WO | claimed |
| US-20190039910-A1 | MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2019-02-07 | — | — | US | claimed |
| CN-104927348-A | Antibacterial and anticoagulant polymer material, preparation method and application thereof | UNIV BEIJING CHEMICAL | 2015-09-23 | — | — | CN | claimed |
| WO-2025080553-A1 | NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20240158476-A1 | MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2024-05-16 | — | — | US | disclosed |
| US-20240139385-A1 | PHOTOTRIGGERABLE NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | UNIV GEORGIA (US) | 2024-05-02 | — | — | US | disclosed |
| US-20240131231-A1 | NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | NATIONAL INSTITUTES OF HEALTH | 2024-04-25 | — | — | US | disclosed |
| WO-2020018488-A1 | ROBUST NITRIC OXIDE-RELEASING POLYMERS AND ARTICLES AND METHODS OF MAKING AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2020-01-23 | — | — | WO | disclosed |
| US-20190039910-A1 | MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2019-02-07 | — | — | US | disclosed |
| US-9566372-B2 | Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly(lactic-co-glycolic acid) additive | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-02-14 | — | — | US | disclosed |
| CN-104927348-A | Antibacterial and anticoagulant polymer material, preparation method and application thereof | UNIV BEIJING CHEMICAL | 2015-09-23 | — | — | CN | disclosed |
| US-20150238662-A1 | SUSTAINED NITRIC OXIDE RELEASE COATING USING DIAZENIUMDIOLATE-DOPED POLYMER MATRIX WITH ESTER CAPPED POLY(LACTIC-CO-GLYCOLIC ACID) ADDITIVE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139385-A1 | PHOTOTRIGGERABLE NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | NOS2, NOS1, NOS3 | FDPS 199/4885ALDH1A1 2519/4885TDP1 1037/4885 |
| US-20240131231-A1 | NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | NOS2, NOS1, NOS3 | FDPS 377/4885ALDH1A1 2686/4885TDP1 1189/4885 |
| US-20210220523-A1 | NO RELEASING COATED PROSTHETIC VASCULAR GRAFTS | NOS2, NOS1, NOS3 | FDPS 2153/4885ALDH1A1 2724/4885TDP1 942/4885 |
| US-20240158476-A1 | MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF | NOS1, NOS2, DDO | FDPS 452/4885ALDH1A1 2327/4885TDP1 2510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.